GlassScriptPhysician profile
Frank V Thomas
NPI 1295796381
$9,733.25
in general payments reported to CMS, 2019-2025
14 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,683 · 2020: $4,033 · 2021: $2,442 · 2022: $99.51 · 2023: $21.06 · 2024: $241 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,880.96 | 2019-2021 | |
| Elite Orthopedics, LLC | $1,401.96 | 2020-2021 | |
| Stryker Corporation | $696.43 | 2019-2025 | Triathlon, Aequalis Perform |
| Pacira Therapeutics, INC. | $227.49 | 2019-2021 | |
| Encore Medical, LP | $221.31 | 2022-2024 | Djo Surgical |
| Anika Therapeutics, INC. | $92.17 | 2024 | X-Twist, Integrity |
| Depuy Synthes Sales INC. | $59.70 | 2019-2021 | |
| Medacta USA, INC. | $36.59 | 2025 | Gmk Sphere |
| Solventum Corporation | $30.15 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Davol INC. | $26.95 | 2024 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $21.06 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Innovation Technologies INC | $13.73 | 2025 | Irrisept |
| Bioventus LLC | $12.49 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.